China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's strengthening regulation of the pharmaceutical sector and expanding national health insurance coverage, along with rising incomes, are all triggering a boom for the country's leading drug makers, according to a new study of the sector